Roundtable Discussion: Rethinking the Business Model for Bacteriophages to Develop Effective Therapies to Take to Market
Time: 11:15 am
day: Conference Day Two
Details:
- How to identify investors and initiatives to give financial support
- Communicating the advantage of bacteriophages to funders as valid alternatives to antibiotics
- How to adapt business models for non-traditional bacteriophage therapies to be economically viable
